Evidence map›Paper›PMID 30833612›Full record

ArticleScientific reports2019

Identification and genetic characterization of a novel Orthobunyavirus species by a straightforward high-throughput sequencing-based approach.

Ohad Shifman, Inbar Cohen-Gihon, Adi Beth-Din, Anat Zvi, Orly Laskar, Nir Paran, Eyal Epstein, Dana Stein, Marina Dorozko, Dana Wolf and 4 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 2 institutions in 1 country.

Ohad ShifmanDepartment of Biochemistry and Molecular Genetics, Israel Institute for Biological Research, Ness Ziona, Israel.
Inbar Cohen-GihonDepartment of Biochemistry and Molecular Genetics, Israel Institute for Biological Research, Ness Ziona, Israel.
Adi Beth-DinDepartment of Biochemistry and Molecular Genetics, Israel Institute for Biological Research, Ness Ziona, Israel.
Anat ZviDepartment of Biochemistry and Molecular Genetics, Israel Institute for Biological Research, Ness Ziona, Israel.
Orly LaskarDepartment of Infectious Diseases, Israel Institute for Biological Research, Ness Ziona, Israel.
Nir ParanDepartment of Infectious Diseases, Israel Institute for Biological Research, Ness Ziona, Israel.
Eyal EpsteinDepartment of Biotechnology, Israel Institute for Biological Research, Ness Ziona, Israel.
Dana SteinDepartment of Biochemistry and Molecular Genetics, Israel Institute for Biological Research, Ness Ziona, Israel.
Marina DorozkoClinical Virology Unit, Hadassah Hebrew University Medical Center, Jerusalem, Israel.
Dana WolfClinical Virology Unit, Hadassah Hebrew University Medical Center, Jerusalem, Israel.
Shmuel YitzhakiIsrael Institute for Biological Research, Ness Ziona, Israel.
Shmuel C ShapiraIsrael Institute for Biological Research, Ness Ziona, Israel.
Sharon MelamedDepartment of Infectious Diseases, Israel Institute for Biological Research, Ness Ziona, Israel.
Ofir IsraeliDepartment of Biochemistry and Molecular Genetics, Israel Institute for Biological Research, Ness Ziona, Israel. ofiri@iibr.gov.il.
Israel Institute for Biological Research · ILHadassah Medical Center · IL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Identification and characterization of novel unknown viruses is of great importance. The introduction of high-throughput sequencing (HTS)-based methods has paved the way for genomics-based detection of pathogens without any prior assumptions about the characteristics of the organisms. However, the use of HTS for the characterization of viral pathogens from clinical samples remains limited. Here, we report the identification of a novel Orthobunyavirus species isolated from horse plasma. The identification was based on a straightforward HTS approach. Following enrichment in cell culture, RNA was extracted from the growth medium and rapid library preparation, HTS and primary bioinformatic analyses were performed in less than 12 hours. Taxonomical profiling of the sequencing reads did not reveal sequence similarities to any known virus. Subsequent application of de novo assembly tools to the sequencing reads produced contigs, of which three showed some similarity to the L, M, and S segments of viruses belonging to the Orthobunyavirus genus. Further refinement of these contigs resulted in high-quality, full-length genomic sequences of the three genomic segments (L, M and S) of a novel Orthobunyavirus. Characterization of the genomic sequence, including the prediction of open reading frames and the inspection of consensus genomic termini and phylogenetic analysis, further confirmed that the novel virus is indeed a new species, which we named Ness Ziona virus.

Indexed as

Genome, ViralHigh-Throughput Nucleotide SequencingOpen Reading FramesOrthobunyavirusPhylogenyRNA, ViralRNA, Viral

Identifiers

PMID30833612
PMCPMC6399452
OpenAlexW2920510988

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.